Related Experiment Video
Updated: Jul 8, 2025

The WATCHMAN Left Atrial Appendage Closure Device for Atrial Fibrillation
Published on: February 28, 2012
Rate Versus Rhythm Control for Atrial Fibrillation.
Edward D Shin1, H Nicole Tran1,2, Nirmala D Ramalingam3
1Department of Medicine, Kaiser Permanente Oakland Medical Center, Oakland, CA, USA.
Atrial fibrillation (AF) management involves balancing anticoagulation with either rate or rhythm control strategies. This article compares the risks and benefits of these approaches for AF patients.
Area of Science:
- Cardiology
- Electrophysiology
Background:
- Atrial fibrillation (AF) is the most common sustained arrhythmia, increasing with age.
- AF is linked to higher risks of heart failure, stroke, cardiac events, and dementia.
Purpose of the Study:
- To compare the risks and benefits of rate control versus rhythm control in managing atrial fibrillation.
- To outline current AF management strategies at Kaiser Permanente Northern California.
Main Methods:
- Review of treatment strategies for atrial fibrillation.
- Comparison of rate control (AV nodal blockers) and rhythm control (AADs, cardioversion, ablation).
Main Results:
- The optimal AF treatment strategy (rate vs. rhythm control) is a subject of ongoing debate.
- Anticoagulation for thromboembolism prophylaxis is a primary treatment goal.
Conclusions:
- Effective management of atrial fibrillation requires careful consideration of anticoagulation, rate control, and rhythm control.
- Individualized treatment plans are crucial for patients with atrial fibrillation.
More Related Videos
28:13Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation
Published on: February 26, 2013
08:10Estimating Bilateral Atrial Function by Cardiovascular Magnetic Resonance Feature Tracking in Patients with Paroxysmal Atrial Fibrillation
Published on: July 20, 2022
Related Concept Videos
Disturbances in Heart Rhythm
Arrhythmias are categorized by their speed, rhythm, and origin. A slow...
Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers
Antiarrhythmic Drugs: Class IV Agents as Calcium Channel Blockers
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...
ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias
Pulse rhythm
Conversely, an irregular pulse pattern is termed dysrhythmia, stemming from disruptions in cardiac...
Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers